Evidence map›Paper›PMID 29907756›Full record

ArticleEuropean journal of human genetics : EJHG2018

Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study.

Patricia Marino, Rajae Touzani, Lionel Perrier, Etienne Rouleau, Dede Sika Kossi, Zou Zhaomin, Nathanaël Charrier, Nicolas Goardon, Claude Preudhomme, Isabelle Durand-Zaleski and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Patricia MarinoInstitut Paoli Calmettes, SESSTIM, Marseille, France. patricia.marino@inserm.fr.
Rajae TouzaniInstitut Paoli Calmettes, SESSTIM, Marseille, France.
Lionel PerrierLéon Berard Cancer Centre, GATE L-SE, UMR-CNRS 5824, Lyon, France.
Etienne RouleauDepartment of Pathology and Medical Biology, Gustave Roussy, Villejuif, France.
Dede Sika KossiRothschild Foundation, Health Economy, Paris, France.
Zou ZhaominGustave Roussy, Etudes et Recherche en économie de la santé, Villejuif, France.
Nathanaël CharrierHôpital Hôtel Dieu, , URC Eco Ile de France, Paris, France.
Nicolas GoardonCancer Comprehensive Center François Baclesse, Cancer Biology and Genetics Laboratory, Caen, France.
Claude PreudhommeCHRU of Lille, Biology & Pathology Center, Laboratory of Hematology, Lille, France.
Isabelle Durand-ZaleskiHôpital Hôtel Dieu, , URC Eco Ile de France, Paris, France.
Isabelle BorgetGustave Roussy, Etudes et Recherche en économie de la santé, Villejuif, France.
Sandrine BaffertRothschild Foundation, Health Economy, Paris, France.
NGSEco Group:

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the publication of the article, it has been noted that there is an error in Table 2. Where 543€ is listed in the final column of the table, this should have been written as 550€.

Identifiers

PMID29907756
PMCPMC6117326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.